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 INTRODUCTION
Paediatric Urinary Tract Infection (UTI) is a microbial 
inflammation of lower urinary tract (cystitis and ure-
thritis), upper urinary tract (urethritis and pyelonephri-
tis [PNA]) or both. UTI is one of the most common 
infections in children and symptoms may be nonspe-
cific, mainly in children under five years old1.
The most important factors contributing to UTI are 
age and sex. In the first three months of life UTI is more 
common in males, after which the prevalence rate 
among females is higher. In full -term neonates the rate 
of UTI is low (0.7%)1. In the literature, UTI prevalence 
in infants aged between two and 24 months with fever 
without any apparent cause is 13.4%2. The prevalence 
rate reported in girls aged one to five years of age is 1 
to 3%, whereas few infections occur in boys in this age 
group1.
PNA can lead to transient and even permanent renal 
parenchymal abnormalities that are visible on dimer-
captosuccinic acid renal scanning (DMSA). However, in 
recent data the true consequences of a post -infectious 
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renal scar (RS) are not clear. The evidence showing the 
association between childhood UTI and chronic kidney 
disease (CKD) in children with structurally normal kid-
neys is scarce and this association is likely weak. Accord-
ing to the literature, the most probable cause of CKD 
in children is not UTI but congenital structural abnor-
malities, renal dysplasia and hypoplasia. Nevertheless, 
It is hard to differentiate between post -infectious RS 
and hypoplasia or dysplasia through image alone3,4.
The rate of post -PNA RS is dependent on several risk 
factors, namely young age, female gender, urinary tract 
anomalies, presence of fever, delay of treatment, num-
ber of UTI episodes, laboratory indices of inflammation 
such as total white blood cell count (WBC) and C -Reac-
tive Protein (CRP) value, and uncommon uropathogens 
(non -Escherichia coli)5,6. Although large -scale studies 
have shown a low rate of renal injury after an episode 
of PNA, the evaluation of renal scarring was not the 
primary objective of these studies5. The true risk of 
renal scarring after a UTI thus remains unknown.
The choice of imaging exams to perform is probably 
the most controversial decision in children with a PNA. 
After a first PNA episode, some authors argue in favour 
of early imaging in order to detect congenital abnor-
malities that may predispose the child to additional 
persistent or recurrent infections and renal damage7,8. 
The noninvasive nature, lack of radiation, and relatively 
low cost of ultrasonography have made it an ideal initial 
screening tool in children after a first PNA episode7. 
Yet, according to some international guidelines, the 
criteria to perform renal and bladder ultrasound (RBUS) 
does not include every children with PNA9,10. DMSA is 
the elected method for detection of RS1. Limitations 
of this exam include its significant cost, exposure to 
radiation, possible need for patient sedation, and lim-
ited availability1. There is no consensus on who must 
undergo DMSA following a UTI. Traditionally, all PNA 
in children younger than 24 months of age are inves-
tigated. However, recent international guidelines argue 
that most DMSA exams following a PNA are normal 
and DMSA use should not be generalized8 -10. There 
are different criteria for performing this exam and there 
is no consensus on which children should undergo it8-
-10. Over -limiting the prescription of DMSA means some 
RS will likely be missed and future consequences on 
renal scarring are not yet known.
The aim of the present study was to: 1) revise the 
cases of PNA; 2) detect the possible predictors for renal 
scarring in cases of PNA; 3) assess the consequences 
of a hypothetical scenario whereby the NICE guidelines 
for initial imaging strategies were followed instead of 
our current clinical practices for PNA.
 SUBJECTS AND METHODS
Case review of clinical files covering a three -year 
period (from January 2013 to December 2015).of chil-
dren under 24 months with PNA evaluated at the pae-
diatrics department of a Lisbon metropolitan area 
hospital
UTI was defined as any proliferation of a single 
bacterial strain obtained through supra -pubic 
approach, growth of 10,00 to 50,000 colony -forming 
units (CFUs) per mL in a sample collected from blad-
der catheterization/supra -pubic aspiration or at least 
100,000 CFUs/mL in a sample obtained from a col-
lecting bag8,10. All children included presented two 
cultures isolating the same microorganism; at least 
one obtained from bladder catheterization or supra-
-pubic approach. We defined PNA based on a con-
firmed UTI as well as the presence of at least one of 
the following criteria of fever no less than 38.0°C or 
loin pain/tenderness9.
Atypical UTI was considered if one of the following 
was documented: isolation of a microorganism rather 
than Escherichia coli, presence of palpable abdominal 
mass, altered renal function, initial presentation as 
sepsis and also no improvement after 48 hours of 
appropriate antibiotherapy9.
Serum for laboratory investigations, including WBC 
and CRP, were taken in some patients, according to 
clinical criteria.
Empirical antimicrobial treatment followed the 
department’s clinical protocol, adjusted according to 
the antibiogram of the uropathogen in each case. Anti-
microbial prophylaxis was prescribed according to our 
department’s clinical protocol. In the first year of this 
study, we prescribed antimicrobial prophylaxis to all 
children with a first PNA and without sphincter control 
of the bladder or to children with uropathy, but in the 
last two years antimicrobial prophylaxis was only pre-
scribed in cases of uropathy or recurrent UTI.
RBUS was performed in every patient at diagnosis. 
We collected information on the kidneys (number, size, 
location, parenchyma features), urinary tract (dilata-
tion, duplicity, wall thickening), and bladder 
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(ureterocele). All abnormal RBUS findings were record-
ed, including the antero -posterior diameter of the 
renal pelvis no less than five millimetres (mm) and/or 
any grade of dilatation of the calyces or ureters irre-
spective of antero -posterior diameter; pelvic or ure-
teral wall thickening; solitary or ectopic kidney; absence 
of cortico -medullary differentiation; duplicated renal 
collecting system, and kidney size discrepancy. Renal 
pelvic wall thickening was defined as thickening meas-
uring greater than one mm. Kidney size discrepancy 
was defined as kidneys dimension discrepancies great-
er than 10 mm.
DMSA was performed at least six months after the 
diagnosis in every patient. Renal asymmetry was con-
sidered as a difference in the analysis of renal quantita-
tive activity equal to or superior than 10%. Renal scar-
ring was defined as evidence of kidney focal or 
generalized areas of persistent diminished radioisotope 
uptake in DMSA.
Children with prenatal history of hydronephrosis, 
neurogenic diseases, history of urogenital or anorectal 
malformations and all those who did not undergo 
follow -up with DMSA were excluded from the study. 
Children with no clinical information on the first UTI 
were also excluded from the study. Children with urine 
samples collected only from a collecting bag were 
excluded. Children with a lower UTI were excluded from 
the study.
The NICE guidelines were used to determine the 
indications for DMSA. According to NICE guidelines, a 
DMSA should be performed only in the presence of an 
atypical or recurrent UTI9.
Data were gathered regarding demographic and clini-
cal facts, laboratory and imageology results, use of 
antimicrobial acute treatment and prophylaxis, type of 
follow -up appointment and family history of renal 
disease.
Statistical analysis was performed using SPSS® 21.0 
(SPSS, INC., Chicago, USA). For numerical variables 
with normal distribution, the mean and standard 
deviation (SD) were calculated. The median, mini-
mum and maximum values were calculated for non-
-normal distribution variables. The comparative 
analysis was performed using a chi -square test or 
Fisher’s exact test for categorical variables. For con-
tinuous variables with normal distribution, the Stu-
dent t -test was performed and the Mann -Whitney 
U test for continuous variables with non -normal 
distribution. Data were analysed as to what the con-
sequences would have been if the NICE guidelines 
had been applied to clinical use in this cohort, with 
regard to “missed” diagnoses.
 RESULTS
 Epidemiology
In the period analysed, there were 59 UTI episodes 
that met the inclusion criteria. There was a slight male 
predominance among the sample (50.8% were boys) 
and the median age was four months (range 13 days 
– 20 months). A total of 44.1% were aged equal to or 
under three months old and 86.4% were aged no more 
than twelve months. The distribution according to age 
group is represented in Figure 1. Only two children 
(3.4%) had reported familiar history of nephro -urologic 
diseases.
 Clinical findings and diagnostic exams
The median length of time between the beginning 
of symptoms and initiating antibiotherapy was one day 
(range 0 – 9 days).
Analysis with WBC and CRP were performed in 86.4% 
children. The mean leukocyte count value was 16.9± 
6.4 x109/mL and median CRP value was 6.81 mg/dL 
(range 0.29 – 27.81mg/dL).
All 59 children had two urine cultures isolating the 
same microorganism. Escherichia coli was the most 
common pathogen isolated in 53 cultures (91.5%) with 
one of these isolating an Extended - Spectrum Beta-
-Lactamase (ESBL) producing Escherichia coli. Proteus 
mirabilis was isolated in 3.4% children, followed by 
Klebisiella pneumoniae, Klebsiella oxytoca and Citro-
bacter koseri all in 1.7%.
Atypical UTI was documented in 7 (11.9%) children: 
four had isolation of microorganisms rather than 
Escherichia coli; two patients did not improve after 48 
hours of appropriate antibiotherapy and one newborn 
that presented with sepsis. There was no difference 
between clinical, laboratory and ultrasound features 
in both groups with and without atypical UTI, except 
in the rate of admission. Children with atypical UTI had 
a smaller rate of admission after UTI diagnosis (2.8% 
vs 26.1%, p=0.011).
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RBUS was performed in every patient either at 
admission or during the first day of therapy. In 36 
(61.0%) children no alterations were documented. A 
total of 16 (27.1%) children had a renal pelvis anter-
oposterior (AP) diameter greater than five millimetres. 
One (1.7%) children presented with pyelocalicial duplic-
ity with ureterocele, and two (3.4%) had an ectopic 
pelvic kidney. Two children (3.4%) had kidney size dis-
crepancies. Poor corticomedullary differentiation was 
described in one child (1.7%) and also one (1.7%) child 
had renal pelvic wall thickening.
 Antibiotic therapy
The majority of children (61.0%) required admission 
to the hospital for intravenous antibiotherapy whereas 
only 23 were discharged home with an oral antibiother-
apy prescription. 94.4% of the admitted patients were 
less than 12 months old. The median age of the children 
discharged home was 9 months (range: 3 – 20 months); 
that of the children hospitalized was two months (range: 
13 days – 20 months). 86.1% of the children hospitalized 
were started on intravenous antibiotherapy and later 
switched to oral therapy, while 5 (13.9%) performed the 
total course of therapy intravenously.
All children started empiric antibiotic therapy. 35 
(59.3%) were started on monotherapy with either 
amoxicillin/clavulanic acid (50.8%), cefuroxime (3.4%) 
and three (5.1%) children that presented with fever, 
elevation of blood infectious parameters but no clinical 
symptoms suggesting UTI started ceftriaxone empiri-
cally. The remaining 24 patients were treated initially 
with combined antibiotherapy either due to their age 
or clinical presentation at diagnosis. 5 (8.5%) children 
less than one month were started on combined therapy 
with cefotaxime and gentamicin; 18 (30.5%) were 
started on amoxicillin/clavulanic acid with gentamicin. 
One (1.7%) child that presented with fever, grunting 
and no specific alteration in urinalysis at the rapid dip-
stick method performed at the emergency department 
was started on cefotaxime combined with ampicillin.
A total of 12 (20.3%) children were initially treated 
with empiric antibiotics that were later revealed to be 
resistant to the isolated bacteria. There were no imme-
diate complications described in any case.
After completing therapy, prophylactic antibiother-
apy with trimethoprim was initiated in 45.8% children. 
This subgroup had a median age of three months 
(range: 14 days – 16 months).
 Follow -up and complications
All children had follow -up hospital appointments 
either with a paediatric nephrology expert (79.7%) or 
a general paediatrician (20.3%).
Renal DMSA scintigraphy was performed in every 
patient. Alterations were documented in 14 (23.7%): 
in five children (8.5%) there was a difference in renal 
activity equal to or superior than 10% but with no focal 
defects; in nine (15.2%) renal scarring was reported. 
Children with renal scarring had a median age of seven 
months (range 1 – 20 months). No information about 
further follow -up was available.
Evaluating children with documented renal scarring 
at scintigraphy, it is possible to compare several param-
eters present at diagnosis with children that did not 
develop this complication.
Concerning gender, there was no significant differ-
ences between boys and girls (13.3% vs 17.2%, p=0.478). 
For age distribution, the group with RS tended to be 
of an older age (7 vs 4 months, p=0.147) with UTI fre-
quently due to other bacteria than Escherichia coli (20% 
vs 14.8%, p=0.577), although not significantly. There 
was no difference in length of time between symptoms 
and initiation of antibiotherapy between the groups 
with and without RS (2.50 vs 1.00; p=0.261). There was 
no association between the development of renal scar-
ring and the initial empirical therapy with a resistant 
antibiotic (8.3% vs 17.0%, p=0.409).
For WBC count at diagnosis, there was no significant 
difference between groups: WBC at diagnosis (16.90± 
3.89 x109 /mL vs 16.92± 6.65x x109 /mL, p=0.995). 
However, CRP level at diagnosis were significantly 
higher in the group with RS (11.15 mg/dL vs 5.44 mg/
dL, p=0.047). Children that had alterations documented 
at the RBUS performed at diagnosis had more RS at 
follow -up (17.4% vs 13.9%, p=0.495), although not sig-
nificantly. When comparing children that were dis-
charged and did performed oral antibiotherapy with 
those who were hospitalized and received, at least 
initially, intravenous antibiotherapy, the first group had 
a tendency toward more RS that the latter (26.1% vs 
8.3%, p=0.071). Finally, we found a tendency to RS in 
the group with atypical UTI (28.6% vs 13.5%, p=0.288), 
although this not significant. Table I illustrates the com-
parison between children with and without RS.
If we had followed 2007 NICE guidelines, we would 
have performed only seven DMSA (11.9%). In the group 
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of non -atypical UTI, the majority had no DMSA alterna-
tions (76.9% from a total of 52 cases). However, follow-
ing 2007 NICE guidelines, we would have missed 12 
DMSA alterations (85.7% of DMSA alterations) in chil-
dren with non -atypical UTI (including seven RS). From 
those with an atypical UTI, 71.4% had a normal DMSA.
 MINI -REVIEW
Acute PNA may sometimes lead to permanent RS 
with possible significant late clinical sequelae3. In our 
study, we detected RS after a first episode of upper 
UTI in 15.3% patients aged under 24 months old, which 
is consistent with the literature (7.2 – 58%)6,7,11 -21. 
The wide range found in the literature results from 
heterogeneous patient populations differing widely in 
age, different diagnostic criteria for UTI, inclusion of 
hospitalized patients or hospitalized and ambulatory 
treated individuals, criteria and timing for performing 
DMSA and ultimately different familiar and personal 
background. Some studies excluded young infants aged 
less than two months old11,13,15 -19. However, Chih-
-Chuan Hsu et al compared a population of infants 
aged less than two months and a population aged two 
to 24 months old, both hospitalized with first febrile 
UTI, and found no differences in clinical characteristics, 
antimicrobial resistance, imaging findings, and clinical 
outcomes21.
The general findings of our study were compatible 
with the literature: upper UTI was predominant in chil-
dren under 12 months old7,15,19 and Escherichia coli 
was isolated in almost 90% urine samples 11,15,16,19 -21. 
Two fifths of the analysed patients had abnormal 
RBUS7,15,19 -21.
According to earlier literature, young age, female 
gender, presence of fever, urinary tract anomalies, delay 
of treatment, number of PNA episodes, laboratory 
indices of inflammation such as total WBC count and 
CRP concentration, and uncommon uropathogens (non-
-Escherichia coli) were correlated with the development 
of renal scars5,6. However, some recent studies have 
failed to show these correlations6,11,19.
Warren T. Snodgrass et al studied children aged 0 
– 18 years old referred for urology assessment after 
diagnosis of febrile UTI and/or vesicoureteral reflux 
(VUR). Their data report a higher likelihood of focal 
DMSA cortical defects in children older than one year 
old versus younger than one year of age (18% versus 
6%, p=0.001), with each year of life increasing the odds 
of having focal DMSA defect(s) after upper UTI (OR=1.2, 
95% CI=1.1 – 1.3)13. A similar association was found 
by Nader Shaikh et al that retrospectively studied chil-
dren younger than six years with a first or second upper 
UTI episode (2 – 11 months: 4%; 12 – 35 months 7%; 
36 – 72 months: 15,9%; p=0,003)17. In our report there 
was a tendency to a higher risk of RS with increasing 
age (7 vs 4 months, p=0.147), which is consistent with 
the literature. However, there are other studies that 
failed to detect association between age and risk of 
RS11,19,20.
Despite previous reports which stated that girls have 
a higher risk of focal renal defects, we found no asso-
ciation between gender and risk of RS (17.2% vs 13.3%, 
p=0.478). This is in agreement with other recent 
studies6,7,12,13,16,17,20.
In a meta -analysis of nine studies of 1280 children 
with a first UTI, temperature of at least 39°C was associ-
ated with RS (p<0.01)12. In this report the grade of 
fever was not analyzed and this could be an important 
factor in the risk of RS, which limits the results.
There was no significant difference in the incidence 
of RS and delay in the initiation of antibiotic therapy 
(2.5 days vs 1 day, p=0.261), which is consistent with 
the literature11,12,16,19. However, in some reports, the 
risk of renal scarring was higher when there was a delay 
greater than 72 hours in starting antibiotherapy19,20. 
Consequently, there seems to be no greater risk of renal 
scarring if the onset of antibiotic therapy is delayed 
until a definitive diagnosis is made in children under 
24 months who present with fever and are otherwise 
well.
In our study, most patients diagnosed with UTI were 
admitted to the hospital (61%) and 94.4% of admissions 
were infants aged less than 12 months. Akshay Sood 
et al studied the rates of hospital admission of paedi-
atric UTI (≤17 years) in the United States of America 
between 2006 – 2011. Children aged less than 12 
months had an admission rate of 22.6% although they 
represent 57.9% of the total admissions22. The huge 
difference between our results and the previous study 
is probably explained due to different criteria of hospital 
admission and because this study also included cystitis. 
We found a tendency to a higher risk of RS among 
infants discharged home (26.1% vs 8.3%, p=0.071). We 
could not find any related data in the literature. This 
is probably related to at -home non -compliance with 
medical treatment but may also be associated with the 
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fact that the children who are discharged home are 
mostly older that the ones who are admitted and in 
this group, as stated before, there was tendency toward 
more RS risk.
Previous studies reported a significant relation 
between WBC and CRP with renal scarring risk12,16,23. 
A meta -analysis that included children aged less than 
seven years old demonstrated that the measurement 
of serum procalcitonin (PCT) can provide considerable 
predictive value for the development of renal scars, 
and that this predictive capacity is better than that 
provided by either CRP or WBC count23. In this report, 
children with RS did not have higher WBC values at 
diagnosis (WBC count: 16.9 ± 3.89 x109 /mL vs 16.92± 
6654x x109 /mL, p=0.995). However, CRP level was 
significantly higher in children with RS (11.15 mg/dL 
vs 5.44 mg/dL, p=0.047). It is important to note that 
not all children performed laboratory analyses and this 
might influence the results. Since these laboratory 
parameters are almost routinely performed in children 
under 24 months old with febrile ITU, prospective stud-
ies must be carried out to confirm the relation described, 
which might have a future influence on follow -up 
approach.
Although recent studies have identified a significant 
relation between RS and non Escherichia coli in urine 
cultures12,19, there are also some reports that do not 
show this association between the pathogen isolated 
and the risk of irreversible renal lesions. In our study, 
isolation of non Escherichia coli In urine seems to 
increase the risk of RS (20% vs 15%, p=0.579).
We obtained an empirical antibiotic resistance of 
20.3% in our study and no difference was found in the 
RS risk and initiating antibiotic therapy with an antibi-
otic that the isolated bacteria was resistant to. This is 
probably explained by the fact that in cases of antibiotic 
resistance, the therapy was changed as soon as the 
urine culture results were known, on average in the 
first 48 hours of treatment.
The number of abnormal RBUS was tendentiously 
higher in patients with renal scaring (17.4% vs 13.9%, 
p=0.495), which is consistent with other stud-
ies7,12,14,16,19,21. According to the Nader Shaikh et al 
meta -analysis, RBUS is an important predictor of RS, 
regardless of age, sex and clinical appearance12. Some 
current guidelines limited the use of RBUS after the 
first UTI to young children or to children with an atypi-
cal UTI, and following this approach it is likely that we 
will have missed some RBUS and DMSA alterations.
Finally, our study seems to reinforce the tendency 
of having RS within atypical UTI cases (28.6% vs 13.5%; 
p=0.288)9.
The follow -up approach after a UTI episode in children 
is being questioned and a consensus has not been reached 
yet. Some investigators argue against limiting the image 
studies to specific subgroups, namely children aged less 
than six months or with atypical UTI, because it could lead 
to missing RS diagnosis with its possible clinical conse-
quences15,18,24,25. Still we must take into account the 
disadvantages of performing an exam such as a DMSA: 
costs, radiation exposure, possible need for patient seda-
tion. So, the question persists: how many useless imaging 
exams are justified to find one patient with renal scarring? 
It’s crucial to find risk factors for RS in order to limit the 
prescription of DMSA after an upper UTI. According to 
our study, atypical UTI, PCR concentration and abnormal 
RBUS seem to be important features that we must include 
in a DMSA prescription algorithm.
This study has several strengths. Data were collected 
from a single centre with a consistent strategy in man-
aging children with UTI. We enrolled hospitalized and 
outpatient children aged up to 24 months with a first 
UTI without previous nephro -urologic malformations. 
We performed late DMSA and RBUS on all included 
patients. The study has also some limitations. Firstly, 
its retrospective nature limits our conclusions. Sec-
ondly, the sample size (59 infants and children) may 
be a major limitation. Thirdly, information about some 
important follow -up information namely recurrent UTI 
was lacking. Besides, both RBUS and DMSA are exams 
with subjective results. Another limitation is not know-
ing the exact time of the onset of infection. The closest 
we were able to come was to document accurately the 
onset of symptoms. Moreover, blood collection was 
inconsistent, and, therefore, there was a substantial 
number of patients with missing laboratorial data. This 
issue is associated with a high risk of bias.
The optimal imaging algorithm for children with UTI 
remains unclear. The choice of performing a DMSA after 
a UTI must be individualized and not generalized to all. 
We must take into account at least age, presence of 
atypical UTI, PCR level and RBUS result when choosing 
which exams to perform. Further prospective studies 
with larger cohorts are warranted to reach a consensual 
clinical guideline.
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